Thermo Fisher Scientific announced that it opened a new clinical and commercial ultra-cold facility in the Netherlands. The company aims to expand its clinical trial network in Europe and accelerate the development of advanced therapies. Its new current good manufacturing practice (cGMP) facility in Bleiswijk offers pharmaceutical and biopharma customers tailored, end-to-end support throughout the…
Thermo Fisher Scientific launches cell therapy manufacturing tech
Thermo Fisher Scientific (NYSE:TMO) announced today that it unveiled the Gibco CTS DynaCellect magnetic separation system. Waltham, Massachusetts-based Thermo Fisher designed DynaCellect to help cell therapy developers easily move from process and clinical development to commercial manufacturing. The next-generation instrument features cell isolation, activation and depletion along with Dynabeads magnetic beads removal. Thermo Fisher said…
Thermo Fisher launches refrigerated vacuum concentrator
Thermo Fisher (NYSE: TMO) is debuting a SpeedVac refrigerated vacuum concentrator to maintain the temperature of heat-sensitive samples, including proteins. The SpeedVac SRF110 modular refrigerated vacuum concentrator offers programmability to allow operators to specify chamber temperature before and after a sample run. The system is available in a modular configuration known as SRF110P1 or in…